Skip to main content
main-content

16-06-2017 | Prostate cancer | Interview | Video

LATITUDE supports first-line abiraterone use for metastatic prostate cancer

Study author Kim Chi explains the impact of the LATITUDE trial study findings for men with newly diagnosed metastatic prostate cancer.

image credits